Bob Lilly had been a staple along the Dallas Cowboys ... Lilly’s sack of Griese stands as the most yards lost on a single play in Super Bowl history. Lilly and the Cowboys defense allowed ...

The Dallas Cowboys rid themselves of the label as the team that couldn't win the big one by defeating the Miami Dolphins 24-3 ...

Timothée Chalamet revealed he “turned over every stone” to transform into Bob Dylan for his Oscar-nominated ... talk like Dylan, play guitar like Dylan, play harmonica like him, walk and ...

Eli Lilly’s idiopathic pulmonary fibrosis deal with Mediar is centered around MTX-463, an anti-WISP1 antibody that early studies have found to be safe and capable of engaging its target. Eli Lilly on ...

The actor said he “turned over every stone” to play the folk icon in 'A Complete ... is sharing that his physical transformation into Bob Dylan for the biopic A Complete Unknown went deeper ...

Earnings Report 5.125 USD Q4 2024 Earnings Release 02/06/2025 Earnings Report 5.041 USD Q1 2025 Earnings Release 05/01/2025 Earnings Report 5.723 USD Q2 2025 Earnings Release 08/07/2025 Earnings ...

Bob Dylan has announced his initial batch of 2025 tour dates, featuring a handful of stops in small towns across the midwest. Billed as a continuation of his “Rough and Rowdy Ways Tour,” the brief run ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50 ...

Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in upfront and near-term payments for global rights to an asset that is ...